Why the study?
Clozapine is the gold standard for treatment-resistant schizophrenia but is underused due to potentially lethal side effects, including clozapine-induced cardiomyopathy, requiring multidisciplinary management.
This case highlights the importance of multidisciplinary collaboration in diagnosing and managing clozapine-induced cardiomyopathy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
L. RUYSSCHAERT (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: